Erschienen in:
01.12.2009 | Preclinical Study
Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model
verfasst von:
Valeria C. Grossoni, Laura B. Todaro, Marcelo G. Kazanietz, Elisa D. Bal de Kier Joffé, Alejandro J. Urtreger
Erschienen in:
Breast Cancer Research and Treatment
|
Ausgabe 3/2009
Einloggen, um Zugang zu erhalten
Abstract
In this paper we investigated whether protein kinase C (PKC) β1 and PKCε, members of the classical and novel PKC family, respectively, induce phenotypic alterations that could be associated with tumor progression and metastatic dissemination in a murine model of breast cancer. Stable overexpression of PKCβ1 in LM3 cells altered their ability to proliferate, adhere, and survive, and impaired their tumorigenicity and metastatic capacity. Moreover, PKCβ1 induced the re-expression of fibronectin, an extracellular matrix glycoprotein which loss has been associated with the acquisition of a transformed phenotype in different cell models, and exerted an important inhibition on proteases production, effects that probably impact on LM3 invasiveness and dissemination. Conversely, PKCε overexpression enhanced LM3 survival, anchorage-independent growth, and caused a significant increase in spontaneous lung metastasis. Our results suggest PKCβ1 functions as an inhibitory protein for tumor growth and metastasis dissemination whereas PKCε drives metastatic dissemination without affecting primary tumor growth.